CNS Pharmaceuticals Inc (CNSP)
0.111
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
0.1124
0.00 (0.00%)
After-Hours: 20:00
CNS Pharmaceuticals Total Liabilities (Quarterly): 4.057M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 113.69M |
| Cellectar Biosciences Inc | 22.13M |
| Revance Therapeutics Inc | 624.59M |
| Zymeworks Inc | 120.17M |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.409M |
| Shareholders Equity (Quarterly) | 3.352M |